-+ 0.00%
-+ 0.00%
-+ 0.00%

Takeda and Protagonist Report Phase 3 Study Shows Rusfertide Sustains Hematocrit Control in Polycythemia Vera

Reuters·12/08/2025 11:19:20

Please log in to view news